IP Verse

Pharmaceutical Composition Containing Rifaximin Alpha & Delta

Patent No. EP3434265 (titled "Pharmaceutical Composition Containing Rifaximin Alpha & Delta") was filed by Sandoz on Mar 22, 2017. The application was issued on Jul 7, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSApr 7, 2022D YOUNG
ALFRED E TIEFENBACHERApr 6, 2022HAMM & WITTKOPP
ALFASIGMAMar 21, 2022KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3434265

SANDOZ
Application Number
EP18193241A
Filing Date
Mar 22, 2017
Status
Revoked
May 24, 2024
Publication Date
Jul 7, 2021
External Links
Slate, Register , Google Patents